Your Results

100 total results

A Lifetime of Care: Dr. Gail S. Wolfe’s 54-Year Journey in Veterinary Medicine - https://cvm.msu.edu/vetschool-tails/a-lifetime-of-care-dr-gail-s-wolfes-54-year-journey-in-veterinary-medicine Spartan researchers share discoveries on eye disease at ARVO Annual Meeting - https://cvm.msu.edu/news/2025/spartan-researchers-share-discoveries-on-eye-disease-at-arvo-annual-meeting

Anneke Moresco, DVM, MSC, PhD - Comparative Theriogenology Fellow

Pale skin lesions cranial to the dorsal fin on the dorsum of farmed rainbow trout fingerlings (Oncorhynchus mykiss) - https://cvm.msu.edu/research-publications/pale-skin-lesions-cranial-to-the-dorsal-fin-on-the-dorsum-of-farmed-rainbow-trout-fingerlings-oncorhynchus-mykiss A Shell-Shocking Coincidence - https://cvm.msu.edu/vetschool-tails/a-shell-shocking-coincidence MSU DVM Students Present at 2025 Therio Conference - https://cvm.msu.edu/vetschool-tails/msu-dvm-students-present-at-2025-therio-conference MSU Researcher Investigates Glaucoma Risk in Shiba Inu Dogs - https://cvm.msu.edu/vetschool-tails/msu-researcher-investigates-glaucoma-risk-in-shiba-inu-dogs $20K in Merck Animal Health Scholarships Awarded to 2025 Food Systems Fellowship Students - https://cvm.msu.edu/news/2025/20k-in-merck-animal-health-scholarships-awarded-to-2025-food-systems-fellowship-students Dr. András Komáromy Appointed to Prestigious NIH Study Section - https://cvm.msu.edu/news/2025/dr-andras-komaromy-appointed-to-prestigious-nih-study-section

Kelly Hume, DVM, DACVIM (Oncology) - Associate Professor of Medical Oncology | 517-353-5420 | humekell@msu.edu

Meghan Johnson, DVM, DACVECC - Assistant Professor of Emergency and Critical Care Medicine

Preferential apical infection and spread of human metapneumovirus highlights the importance of inhaled delivery of neutralizing monoclonal antibody to treat established infections - https://cvm.msu.edu/research-publications/preferential-apical-infection-and-spread-of-human-metapneumovirus-highlights-the-importance-of-inhaled-delivery-of-neutralizing-monoclonal-antibody-to-treat-established-infections